AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zemel, P. C.
Right arrow Articles by Sowers, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zemel, P. C.
Right arrow Articles by Sowers, J. R.
Agricola
Right arrow Articles by Zemel, P. C.
Right arrow Articles by Sowers, J. R.

American Journal of Clinical Nutrition, Vol 51, 665-669, Copyright © 1990 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension

PC Zemel, MB Zemel, M Urberg, FL Douglas, R Geiser and JR Sowers
Division of Endocrinology, Nutrition and Hypertension, Wayne State University, School of Medicine, Detroit, MI.

The effect of magnesium supplementation on blood pressure, erythrocyte cation metabolism, and serum lipids was evaluated in 13 patients with mild hypertension. After randomization and a 3-wk placebo run-in period, seven patients received 40 mmol Mg aspartate (20 mmol elemental Mg twice daily) and six received placebo for 3 mo. In comparison with placebo treatment, magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism. These results demonstrate that in magnesium-repleted hypertensive subjects, magnesium supplementation does not affect blood pressure or lipids probably because magnesium has no effect on cellular cation metabolism in magnesium-replete individuals.


This article has been cited by other articles:


Home page
HypertensionHome page
Y. Kawano, H. Matsuoka, S. Takishita, and T. Omae
Effects of Magnesium Supplementation in Hypertensive Patients : Assessment by Office, Home, and Ambulatory Blood Pressures
Hypertension, August 1, 1998; 32(2): 260 - 265.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. M. Sacks, W. C. Willett, A. Smith, L. E. Brown, B. Rosner, and T. J. Moore
Effect on Blood Pressure of Potassium, Calcium, and Magnesium in Women With Low Habitual Intake
Hypertension, January 1, 1998; 31(1): 131 - 138.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. M. Sacks, L. E. Brown, L. Appel, N. O. Borhani, D. Evans, and P. Whelton
Combinations of Potassium, Calcium, and Magnesium Supplements in Hypertension
Hypertension, December 1, 1995; 26(6): 950 - 956.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by The American Society for Nutrition